Crotalus scutulatus antivenin

DB13891ApprovedProtein Based TherapiesAntivenins

Crotalus scutulatus antivenin is a mixture of antibodies used to treat venomous snake bites from Crotalus scutulatus (Mojave rattlesnake). Crotalus scutulatus antivenin is derived and purified immunoglobulin fragments obtained from other domestic animals such as sheep previously immunized with Crotalus scutulatus (also known as the Mojave rattlesnake).

Mechanism
Curator reviewed
Primary indication
CROFAB is indicated for the management of adult and pediatric patients with North American crotalid envenomation.Curator reviewed · 1 structured indication
First approval
United States, 2000
Also known as
Crotalus scutulatus immune fab antivenin (ovine)
Brand names
  • Crofab

Resolves to

Clinical / RWD

What you can answer from here — as of April 02, 2025

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Crotalus scutulatus antivenin, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account